Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-30

Clinical Trial Update: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating cerebral small vessel disease in a patient with primary aldosteronism; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Evaluation of Cerebral Small Vessel Disease in Patient With Primary Aldosteronism | Phase 1 | Status: UNKNOWN